Funded by the German Federal Ministry of Education and Research, the ExploreCOVID project aims to analyze patient history and clinical as well as imaging data across multiple medical centers to identify standardizable diagnostic criteria. By doing so, a comprehensive database of structured data will be established which can be used for future epidemiological insights and the risk stratification of COVID-19 patients.
Current evidence indicates that chest CT imaging may be a valuable tool in the diagnosis, epidemiology, and therapy response evaluation of COVID-19 patients. It offers high sensitivity, short turnaround times, and wide availability. Therefore, chest CT may complement RT-PCR tests, especially in situations of unclear clinical presentation, such as a negative RT-PCR despite strong anamnestic evidence for COVID-19. More importantly, it offers opportunities to assess disease progression directly and may be a method of choice for therapy response assessment in upcoming trials of new therapeutic agents. However, to develop it into a proper instrument, a standardized quantitative approach is required. Additionally, multicentric cooperation is essential to generate a sufficiently large database with a consistently high data quality, which is crucial for modern data mining methods.
All centers involved in this project are provided with access to the COVID-19 functionality within the mint Lesion™ platform. The study centers can conduct structured reads on already available thoracic CT images, extract a wide range of image-based parameters (including radiomics parameters), associate them with other clinical and anamnestic data, and then transfer the resulting structured data to the project partners to identify the parameters relevant for the diagnosis and staging of COVID-19. Despite the very high number of different data sources, this approach guarantees that uniform and homogenous criteria are applied in the data extraction.
The results can be immediately implemented in the mint Lesion™ reading template and distributed worldwide for use in diagnostic procedures and therapy response assessments in clinical trials.
ExploreCOVID: An explorative cohort study to identify optimal CT imaging biomarkers in combination with clinical markers and PCR-RT for the diagnosis and therapy response assessment of COVID-19
Related Resources
Related Resources
Structured Reporting of Solid and Cystic Pancreatic Lesions in CT and MRI: Consensus-Based Reporting Templates of the German Radiological Society (DRG)
During the daily clinical routine, radiological reports on pancreatic lesions are often written as freeform texts. This causes several problems, in…
University of Miami & Nova Souteastern University: Study shows feasibility of radiomics and T2 mapping as novel imaging biomarkers of activity in superficial fibromatosis
A retrospective study [1] conducted by researchers at University of Miami Miller School of Medicine and Nova Southeastern University investigated…
The benefits of structured oncologic reporting with mint Lesion™
Dr. Damiano Caruso of Sapienza Universita di Roma recounts how he got to know mint Lesion™ at a workshop hosted by the ESOI. Among other workstations,…